11/15
12:35 pm
aciu
AC Immune's stock jumps after Parkinson's therapy shows signs of benefit [Yahoo! Finance]
Medium
Report
AC Immune's stock jumps after Parkinson's therapy shows signs of benefit [Yahoo! Finance]
11/15
08:04 am
aciu
AC Immune SA (NASDAQ: ACIU) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $16.00 price target on the stock.
Medium
Report
AC Immune SA (NASDAQ: ACIU) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $16.00 price target on the stock.
11/14
02:54 pm
aciu
GSK Raises Prospects For Withdrawn Blood Cancer Drug Blenrep To Return To US Market - Here's Why [Yahoo! Finance]
Medium
Report
GSK Raises Prospects For Withdrawn Blood Cancer Drug Blenrep To Return To US Market - Here's Why [Yahoo! Finance]
11/14
07:09 am
aciu
AC Immune Reports Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson's Disease [Yahoo! Finance]
Medium
Report
AC Immune Reports Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson's Disease [Yahoo! Finance]
11/14
07:00 am
aciu
AC Immune Reports Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson’s Disease
Medium
Report
AC Immune Reports Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson’s Disease
11/13
07:00 am
aciu
AC Immune to Present at the Jefferies 2024 London Healthcare Conference
Medium
Report
AC Immune to Present at the Jefferies 2024 London Healthcare Conference
11/12
04:12 pm
aciu
Climb Bio Reports Third Quarter 2024 Financial Results and Business Highlights [Yahoo! Finance]
Medium
Report
Climb Bio Reports Third Quarter 2024 Financial Results and Business Highlights [Yahoo! Finance]
11/9
08:53 am
aciu
AC Immune SA Beat Analyst Profit Forecasts, And Analysts Have New Estimates [Yahoo! Finance]
Low
Report
AC Immune SA Beat Analyst Profit Forecasts, And Analysts Have New Estimates [Yahoo! Finance]
11/6
08:07 am
aciu
AC Immune SA (NASDAQ: ACIU) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $16.00 price target on the stock.
Medium
Report
AC Immune SA (NASDAQ: ACIU) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $16.00 price target on the stock.
11/5
07:00 am
aciu
AC Immune Reports Third Quarter 2024 Financial Results and Provides a Corporate Update
High
Report
AC Immune Reports Third Quarter 2024 Financial Results and Provides a Corporate Update
10/28
09:06 am
aciu
AC Immune SA (NASDAQ:ACIU) stock most popular amongst individual investors who own 32%, while private equity firms hold 29% [Yahoo! Finance]
Low
Report
AC Immune SA (NASDAQ:ACIU) stock most popular amongst individual investors who own 32%, while private equity firms hold 29% [Yahoo! Finance]
10/1
02:08 am
aciu
AC Immune SA (NASDAQ: ACIU) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Medium
Report
AC Immune SA (NASDAQ: ACIU) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
9/23
11:07 pm
aciu
AC Immune SA (NASDAQ: ACIU) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Low
Report
AC Immune SA (NASDAQ: ACIU) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
9/18
08:05 am
aciu
AC Immune SA (NASDAQ: ACIU) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $16.00 price target on the stock.
Medium
Report
AC Immune SA (NASDAQ: ACIU) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $16.00 price target on the stock.
9/17
07:00 am
aciu
AC Immune Receives Second Milestone Payment Following Progress in Phase 2b ReTain Trial of ACI-35.030 in Preclinical Alzheimer’s Disease
Medium
Report
AC Immune Receives Second Milestone Payment Following Progress in Phase 2b ReTain Trial of ACI-35.030 in Preclinical Alzheimer’s Disease
8/29
07:44 am
aciu
FDA grants fast track designation to Life Molecular Imaging's tau PET diagnostic [Yahoo! Finance]
Medium
Report
FDA grants fast track designation to Life Molecular Imaging's tau PET diagnostic [Yahoo! Finance]
8/28
09:31 am
aciu
Life Molecular Imaging Receives FDA Fast Track Designation for [18F]PI-2620 in Tau PET Imaging Across Three Neurodegenerative Conditions [Yahoo! Finance]
Low
Report
Life Molecular Imaging Receives FDA Fast Track Designation for [18F]PI-2620 in Tau PET Imaging Across Three Neurodegenerative Conditions [Yahoo! Finance]
8/28
09:00 am
aciu
AC Immune’s PI-2620 Tau-PET Diagnostic in Phase 3 Receives Fast Track Designation in Three Neurodegenerative Conditions
Low
Report
AC Immune’s PI-2620 Tau-PET Diagnostic in Phase 3 Receives Fast Track Designation in Three Neurodegenerative Conditions